Incidence of cancers and autoimmune diseases in myasthenia gravis (MG) patients with and without thymectomy | Synapse
March 3, 2026
Incidence of cancers and autoimmune diseases in myasthenia gravis (MG) patients with and without thymectomy
Key Points
Incidence of cancers and autoimmune diseases differs significantly between myasthenia gravis patients depending on thymectomy status, highlighting its impact.
Increased autoimmune disease incidence was observed in MG patients without thymectomy, indicating a possible correlation to cancer risk.
Observational analysis focusing on MG patients revealed insights into the relationship between thymectomy and disease incidence.
Understanding these differences may enable targeted management strategies for myasthenia gravis patients with distinct cancer and autoimmune disease risks.